• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2007 Fiscal Year Final Research Report Summary

Study of molecular basis for T cell-mediated recognition of antigens in subjects with HLA-A3 super type

Research Project

Project/Area Number 18310147
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Living organism molecular science
Research InstitutionKurume University

Principal Investigator

ITOH Kyogo  Kurume University, Sch. Med, Dep. Immunol., Professor (50125499)

Co-Investigator(Kenkyū-buntansha) YAMADA Akira  Kurume University, Research Center for Innovative Cancer Therapy, Professor (50158177)
YUTANI Shigeru  Kurume University, Sch. Med, Associate Professor (20279160)
NOGUCHI Masanori  Kurume University, Sch. Med, Assistant Professor (10140691)
SAKAMOTO Kikuo  Kurume University, Sch. Med, Assistant Professor (70279222)
SHIICHIJO Shigeki  Kurume University, Sch. Med, Associate Professor (30080592)
Project Period (FY) 2006 – 2007
Keywordscancer / virus / allergy / biotechnology / immunology
Research Abstract

1. Cancer associated antigen-derived peptides: We have identified new peptides from SART3 and Lck antigens that are recognized by HLA-A3 super family-restricted cytotoxic T lymphocytes (CTL) (Minami, et. Al., Cancer Immunol. Immunoth.: Naito, et. Al., Brit.J.Can. 2007).
2. Exogenous antigen-derived peptides: We have identified new peptides from hepatitis C virus sequences that are recognized by HLA-A3 super family-restricted CTL (Matsueda, et. Al., Cancer Immunol Immunotherapy, 2007). Furthermore, we found that measurement of lgG antibodies specific to core region of hepatitis C virus at positions 35-44 (C35-44) is a possible new diagnostic tool of hepatitis C virus infection (Takao, et. Al., Med. Mirobiol. Immunol., 2007).
3. Self antigen-derived peptides: We have identified new peptides from self antigens that are recognized by HLA-A3 super family-restricted CTL (Matsueda, et. Al., J. Immunotherpy 2007).
4. Summary: We have obtained new evidence during the past two years with regard to molecular basis of T cell-mediated recognition of antigens in both healthy donors and cancer patients belonging to HLA-A3 super type (HLA-A3,-A 11, -A31, and-A33). The binding motifs of these newly identified peptides to HLA-class IA alleles of HLA-A3 super type were mostly unpredictable from the currently available database of MHC binding peptides predicting the binding of peptides to HLA-class IA alleles of A3 super type. These results indicate that the binding motifs of CTL epitopes to HLA-class IA alleles of HLA-A3 super type are different form those expected in the past. The results created in this grant shall facilitate to better understanding of host responses to cancer cells as well as viral antigens in subjects of HLA-A3 super type, and may contribute to development of new database of MHC binding peptides.

  • Research Products

    (26 results)

All 2007 2006

All Journal Article (20 results) (of which Peer Reviewed: 7 results) Presentation (4 results) Patent(Industrial Property Rights) (2 results) (of which Overseas: 1 results)

  • [Journal Article] Combination therapy of personalized peptide vaccination with low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients:an analysis of prognostic factors in the treatment2007

    • Author(s)
      Noguchi M, Itoh K, et. al.
    • Journal Title

      Oncol Res 16

      Pages: 341-349

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus(HCV)1b who failed to respond to interferon-based therapy2007

    • Author(s)
      Yutani S, Itoh K, et. al.
    • Journal Title

      Vaccine 25

      Pages: 7429-35

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles2007

    • Author(s)
      Minami T, Itoh K, et. al.
    • Journal Title

      Cancer Immunol Immunother 56

      Pages: 689-698

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection,while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients2007

    • Author(s)
      Takao Y, Itoh K, et. al.
    • Journal Title

      Med Microbiol Immunol 196

      Pages: 157-164

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11,-A31 and -A332007

    • Author(s)
      Matsueda S, Itoh K, et. al.
    • Journal Title

      Cancer Immunol Immunother 56

      Pages: 1359-66

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles2007

    • Author(s)
      Matsueda S, Itoh K, et. al.
    • Journal Title

      J Immunother 30

      Pages: 274-281

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles2007

    • Author(s)
      Naito M, Itoh K, et. al.
    • Journal Title

      British J Cancer 97

      Pages: 1648-1654

    • Description
      「研究成果報告書概要(和文)」より
    • Peer Reviewed
  • [Journal Article] Combination therapy of personalized peptide vaccination with low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients : an analysis of prognostic factors in the treatment.2007

    • Author(s)
      Noguchi M, Mine T, Yamada A, Obata Y, Yoshida K, Mizoguchi J, Harada M, Suekane S, Itoh K, Matuoka K
    • Journal Title

      Oncol Res 16

      Pages: 341-349

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.2007

    • Author(s)
      Minami T, Matsueda S, Takedatsu H, Tanaka M, Noguchi M, Uemura H, Itoh K, Harada M
    • Journal Title

      Cancer Immunol Immunother. 56

      Pages: 689-698

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Serum levels of IgG to the peptide of HCVlb core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.2007

    • Author(s)
      Takao Y, Yamada A, Yutani S, Ono T, Nagao Y, Ando E, Ide T, Itoh K, Sata M
    • Journal Title

      Med Microbiol Immunol. 196

      Pages: 157-164

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] A new epitope peptide derived from hepatitis C virus lb possessing the capacity to induce cytotoxic T-lymphocytes in HCVlb-infected patients with HLA-A11, -A31 and -A33.2007

    • Author(s)
      Matsueda S, Yamada A, Takao Y, Tamura M, Komatsu N, Yutani S, Ide T, Sata M, Itoh K
    • Journal Title

      Cancer Immunol Immunother. 56

      Pages: 1359-66

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus(HCV) lb who failed to respond to interferon-based therapy.2007

    • Author(s)
      Yutani S, Yamada A, Yoshida K, Takao Y, Tamura M, Komatsu N, Ide T, Tanaka M, Sata M, Itoh K
    • Journal Title

      Vaccine 25

      Pages: 7429-35

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles.2007

    • Author(s)
      Matsueda S, Takedatsu H, Sasada T, Azuma K, Ishihara Y, Komohara Y, Noguchi M, Shichijo S, Itoh K, Harada M
    • Journal Title

      J Immunother 30

      Pages: 274-281

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Identification of Lek-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles.2007

    • Author(s)
      Naito M, Komohara Y, Ishihara Y, Noguchi M, Yamashita Y, Shirakusa T, Yamada A, Itoh K, Harada M
    • Journal Title

      British J Cancer 97

      Pages: 1648-1654

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Personalized peptide vaccination for cancer patient.2007

    • Author(s)
      Itoh K, Noguti M, Yamanaka R, Yamada A, Shichijo S
    • Journal Title

      The 27th General Assembly of the Japan Medical Congress.(Osaka) 4/6-8

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Identification of a peptide derived from HCV inducing cellular responses with various HLA class I -A alleles.2007

    • Author(s)
      Shichijo S, Komohara Y, Matsueda S, Yutani S, Komatsu N, Sata M, Yamada A, Itoh K
    • Journal Title

      The 66th Annual Meeting of the Japanese Cancer Association.(Yokohama) 10/3-5

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis.2006

    • Author(s)
      Yamada A, Yano H, Takao Y, Ono T, Matsumoto T, Itoh K
    • Journal Title

      J Immunol 176

      Pages: 857-863

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432.2006

    • Author(s)
      Ono T, Harada M, Yamada A, Tanaka M, Takao Y, Tanaka Y, Mine T, Sakamoto K, Nakashima T, Itoh K
    • Journal Title

      Clin Cancer Res 12

      Pages: 1325-1332

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Identification of hepatitis C virus(HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.2006

    • Author(s)
      Wang Y, Takao Y, Harada M, Komatsu N, Ono T, Sata M, Itoh, K, Yamada A
    • Journal Title

      Cell Immunol 241

      Pages: 38-46

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] New epitope peptides derived from hepatitis C virus(HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.2006

    • Author(s)
      Wang Y, Takao Y, Harada M, Yutani S, Ide T, Sata M, Itoh K, Yamada A
    • Journal Title

      Microbiol Immunol 50

      Pages: 857-865

    • Description
      「研究成果報告書概要(欧文)」より
  • [Presentation] Identification of a peptide derived from HCV inducing cellular responses with various HLA class I-A alleles2007

    • Author(s)
      Shichijo S, Itoh K, et. al.
    • Organizer
      第66回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      20071003-05
    • Description
      「研究成果報告書概要(和文)」より
  • [Presentation] Identification of a peptide derived from HCV inducing cellular responses with various HLA class I -A alleles.2007

    • Author(s)
      Shichijo S, Komohara Y, Matsueda S, Yutani S, Komatsu N, Sata M, Yamada A, Itoh K
    • Organizer
      The 66th Annual Meeting of the Japanese Cancer Association.
    • Place of Presentation
      Yokohama
    • Year and Date
      20071003-05
    • Description
      「研究成果報告書概要(欧文)」より
  • [Presentation] テーラーメイド癌ペプチドワクチン開発の現状と展望2007

    • Author(s)
      伊東 恭悟, 他4名
    • Organizer
      第27回日本医学会総会
    • Place of Presentation
      大阪
    • Year and Date
      20070406-08
    • Description
      「研究成果報告書概要(和文)」より
  • [Presentation] Personalized peptide vaccination for cancer patient.2007

    • Author(s)
      Itoh K, Noguti M, Yamanaka R, Yamada A, Shichijo S
    • Organizer
      The 27th General Assembly of the Japan Medical Congress.
    • Place of Presentation
      Osaka
    • Year and Date
      20070406-08
    • Description
      「研究成果報告書概要(欧文)」より
  • [Patent(Industrial Property Rights)] HLA-A3スーパータイプアレル陽性前立腺癌患者に対する癌ワクチン療法に有用なSART3由来ペプチド2007

    • Inventor(s)
      伊東 恭悟, 原田 守
    • Industrial Property Rights Holder
      学校法人久留米大学
    • Industrial Property Number
      PCT/JP2007/063838
    • Filing Date
      2007-07-11
    • Description
      「研究成果報告書概要(和文)」より
    • Overseas
  • [Patent(Industrial Property Rights)] HLA-A3スーパータイプの患者に対するがんワクチンのためのLck-由来ペプチドの同定2007

    • Inventor(s)
      伊東 恭悟, 野口 正典, 原田 守
    • Industrial Property Rights Holder
      学校法人久留米大学
    • Industrial Property Number
      特願2007-212179
    • Filing Date
      2007-08-16
    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 2010-02-04  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi